查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605781

临床风险分组解决方案市场，按组件、应用程式、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Clinical Risk Grouping Solution Market, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年临床风险分组解决方案市值为7.049亿美元，2024年至2032年复合年增长率为14.10%。

临床风险分组解决方案市场-市场动态

对高效人口健康管理的需求不断增长，加上电子健康记录 (EHR) 的使用不断扩大，预计将推动市场成长。

人口健康管理（PHM）的重点是透过解决各种健康决定因素来改善个体群体的健康结果。 EHR 系统的广泛采用带来了集中且可存取的患者资料。临床风险分组解决方案利用这些资料对患者风险进行全面评估，确保医疗保健提供者拥有有效决策所需的资讯。根据美国医院协会的数据，截至 2021 年，近五分之四的基层开业医师(78%) 和几乎所有非联邦急诊医院 (96%) 采用了经过认证的 EHR。此外，新兴经济体越来越多地采用数位健康解决方案来改善医疗保健服务，这带来了巨大的市场机会。然而，资料隐私和安全问题可能会阻碍市场成长。

临床风险分组解决方案市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 14.10% 左右的复合年增长率成长

根据组件细分，预计软体将在 2023 年显示最大的市场份额

从应用细分来看，人口健康管理是2023年的主导部分

根据最终用户细分，医院和诊所行业是 2023 年的领先组成部分

按地区划分，北美是 2023 年的主要收入来源

临床风险分组解决方案市场-細項分析：

全球临床风险分组解决方案市场根据组件、应用程式、最终用户和区域进行细分。

市场依组件分为三类：软体和服务。软体领域在市场上占据主导地位。临床风险分组解决方案市场以旨在评估和管理医疗机构内临床风险的软体解决方案为中心。

根据应用，市场分为两个部分：人口健康管理、慢性病管理、临床决策支援、诈欺检测和预防等。人口健康管理是市场的主导部分。临床风险分组解决方案市场正在逐步与人口健康管理保持一致，因为医疗保健提供者旨在改善患者护理并有效管理人口健康。

根据最终用户，市场分为两个主要类别：医院和诊所、门诊手术中心、长期照护中心等。医院和诊所行业是市场成长的主要驱动力。该行业正在经历扩张，因为它强调透过有效的风险评估和管理来提高患者安全和优化临床护理。

临床风险分组解决方案市场 - 地理洞察

市场地域广阔，涵盖北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些领域根据对商业活动做出贡献的国家进一步细分。北美在市场扩张方面处于领先地位，这主要是由于医疗保健 IT 基础设施投资的增加。美国政府已实施多项措施来改善医疗保健 IT 系统，其中包括《HITECH 法案》，该法案鼓励医疗保健提供者采用电子健康记录 (EHR) 和其他健康 IT 解决方案。这种重视导致了对先进技术的大量投资，例如临床风险分组解决方案。 2021年，美国将国内生产毛额（GDP）的17.8%用于医疗保健，几乎是经合组织国家平均支出的两倍。由于人们对慢性病的认识不断提高，欧洲成为市场成长的第二大地区。

临床风险分组解决方案市场-竞争格局：

临床风险分组解决方案市场的竞争日益激烈，许多参与者都致力于提供根据医疗保健提供者的需求量身定制的尖端解决方案。组织正在对人工智慧和机器学习等先进技术进行大量投资，以提高其风险分组产品的预测功能。这种创新对于维持竞争优势至关重要。随着医疗保健格局不断变化，那些强调创新、互通性和监管合规性，同时有效满足医院和诊所需求的公司将处于成功的最佳位置。

最新进展：

2021 年 4 月 1 日，3M 健康资讯系统推出了一个创新技术平台，旨在使医疗保健提供者和付款人能够专注于被确定为高风险的个人和患者群体的护理优先级和资源分配。

目录

第 1 章：临床风险分组解决方案市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 临床风险分组解决方案市场片段（按组件）
    • 临床风险分组解决方案市场片段（按应用）
    • 最终用户的临床风险分组解决方案市场片段
    • 按国家/地区分類的临床风险分组解决方案市场片段
    • 按地区分類的临床风险分组解决方案市场片段
  • 竞争洞察

第 3 章：临床风险分组解决方案主要市场趋势

  • 临床风险分组解决方案市场驱动因素
    • 市场驱动因素的影响分析
  • 临床风险分组解决方案市场限制
    • 市场限制影响分析
  • 临床风险分组解决方案市场机会
  • 临床风险分组解决方案市场未来趋势

第 4 章：临床风险分组解决方案产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：临床风险分组解决方案市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：临床风险分组解决方案市场格局

  • 2023 年临床风险分组解决方案市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：临床风险分组解决方案市场 - 按组件

  • 概述
    • 按组成部分分類的细分市场占有率分析
    • 软体
      • 私有云端
      • 公共云端
      • 混合云端
    • 服务

第 8 章：临床风险分组解决方案市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 人口健康管理
    • 慢性病管理
    • 临床决策支持
    • 诈欺检测与预防
    • 其他

第 9 章：临床风险分组解决方案市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 门诊手术中心
    • 长期照护中心
    • 其他

第 10 章：临床风险分组解决方案市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 临床风险分组解决方案北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按组成部分）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 临床风险分组解决方案欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按组成部分）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 临床风险分组解决方案亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按组成部分）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 临床风险分组解决方案拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按组成部分）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 临床风险分组解决方案中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 临床风险分组解决方案产业

  • 竞争仪表板
  • 公司简介
    • 3M Corporation
    • 4S Dawn Clinical Software
    • Apixio
    • Cotiviti Inc.
    • Evolent
    • HBI Solutions
    • Health Catalyst, Inc.
    • HealthEC LLC
    • Lightbeam Health Solutions
    • MedeAnalytics, Inc.
    • Nuance Communications, Inc.
    • Optum, Inc.
    • RELX (LexisNexis Risk Solution)
    • ZeOmega
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4190

REPORT HIGHLIGHT

The Clinical Risk Grouping Solution Market was valued at USD 704.90 million in 2023 and expanded at a CAGR of 14.10% from 2024 to 2032.

A Clinical Risk Grouping Solution represents a structured methodology employed in the healthcare sector to classify patients according to their clinical risks and requirements. This approach assists healthcare professionals in stratifying patients, thereby improving management, resource distribution, and the overall delivery of care. Such solutions are frequently utilized across diverse healthcare environments, including hospitals, managed care organizations, and public health programs, to optimize patient care and enhance operational effectiveness.

Clinical Risk Grouping Solution Market- Market Dynamics

The increasing need for efficient population health management, coupled with the expanding utilization of electronic health records (EHR), is anticipated to propel market growth.

Population health management (PHM) focuses on improving the health outcomes of groups of individuals by addressing various health determinants. The widespread adoption of EHR systems has resulted in centralized and accessible patient data. Clinical Risk Grouping Solutions leverage this data to conduct comprehensive assessments of patient risks, ensuring that healthcare providers have the information needed for effective decision-making. According to the American Hospital Association, as of 2021, nearly 4 in 5 office-based physicians (78%) and nearly all non-federal acute care hospitals (96%) adopted a certified EHR. Furthermore, Emerging economies are increasingly adopting digital health solutions to improve healthcare delivery, which presents significant market opportunities. However, Data Privacy and Security Concerns may hampers the market growth.

Clinical Risk Grouping Solution Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.10% over the forecast period (2024-2032)

Based on Component segmentation, software was predicted to show maximum market share in the year 2023

Based on Application segmentation, Population Health Management was the leading Component in 2023

Based on End-User segmentation, Hospitals, and clinics sector was the leading Component in 2023

Based on region, North America was the leading revenue generator in 2023

Clinical Risk Grouping Solution Market- Segmentation Analysis:

The Global Clinical Risk Grouping Solution Market is segmented based on Component, Application, End-User, and Region.

The market is segmented into three categories according to components: software and services. The software segment holds a dominant position in the market. The Clinical Risk Grouping Solution market is centered on software solutions aimed at evaluating and managing clinical risk within healthcare organizations.

The market is categorized into two segments based on application: Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Population Health Management is the leading segment within the market. The Clinical Risk Grouping Solution market is progressively aligning with Population Health Management as healthcare providers aim to improve patient care and effectively manage population health.

The market is classified into two primary categories according to End-User: Hospitals and clinics, Ambulatory surgical centers, Long-term care centers, and others. The Hospitals and clinics sector is the primary driver of market growth. This sector is experiencing expansion as it emphasizes improving patient safety and optimizing clinical care through effective risk assessment and management.

Clinical Risk Grouping Solution Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America leads in market expansion, primarily due to increased investments in healthcare IT infrastructure. The U.S. government has implemented several initiatives to improve healthcare IT systems, including the HITECH Act, which encourages healthcare providers to adopt electronic health records (EHRs) and other health IT solutions. This emphasis has resulted in substantial investments in advanced technologies, such as Clinical Risk Grouping Solutions. In 2021, the United States allocated 17.8 percent of its gross domestic product (GDP) to healthcare, nearly double the average expenditure of OECD countries. Europe ranks as the second largest region for market growth, driven by a rising awareness of chronic diseases.

Clinical Risk Grouping Solution Market- Competitive Landscape:

The market for Clinical Risk Grouping Solutions is becoming progressively competitive, with a multitude of participants aiming to deliver cutting-edge solutions tailored to the requirements of healthcare providers. Organizations are making significant investments in advanced technologies, including artificial intelligence and machine learning, to improve the predictive functionalities of their risk grouping offerings. Such innovation is essential for sustaining a competitive edge. As the healthcare landscape continues to transform, those companies that emphasize innovation, interoperability, and regulatory compliance while effectively addressing the demands of hospitals and clinics will be optimally positioned for success.

Recent Developments:

On April 1, 2021, 3M Health Information Systems launched an innovative technology platform designed to enable healthcare providers and payers to focus on care prioritization and resource allocation for individuals and patient groups identified as high-risk.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Corporation
  • 4S Dawn Clinical Software
  • Apixio
  • Cotiviti Inc.
  • Evolent
  • HBI Solutions
  • Health Catalyst, Inc.
  • HealthEC LLC
  • Lightbeam Health Solutions
  • MedeAnalytics, Inc.
  • Nuance Communications, Inc.
  • Optum, Inc.
  • RELX (LexisNexis Risk Solution)
  • ZeOmega
  • Others

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Private Cloud
  • Public Cloud
  • Hybrid Cloud
  • Services

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Population health management
  • Chronic disease management
  • Clinical decision support
  • Fraud detection and prevention
  • Other

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & clinics
  • Ambulatory surgical centers
  • Long-term care centers
  • Other

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Risk Grouping Solution Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Risk Grouping Solution Market Snippet by Component
    • 2.1.2. Clinical Risk Grouping Solution Market Snippet by Application
    • 2.1.3. Clinical Risk Grouping Solution Market Snippet by End-User
    • 2.1.4. Clinical Risk Grouping Solution Market Snippet by Country
    • 2.1.5. Clinical Risk Grouping Solution Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Risk Grouping Solution Key Market Trends

  • 3.1. Clinical Risk Grouping Solution Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Risk Grouping Solution Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Risk Grouping Solution Market Opportunities
  • 3.4. Clinical Risk Grouping Solution Market Future Trends

4. Clinical Risk Grouping Solution Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Risk Grouping Solution Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Risk Grouping Solution Market Landscape

  • 6.1. Clinical Risk Grouping Solution Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Risk Grouping Solution Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 7.1.2. Software
      • 7.1.2.1. Private Cloud
      • 7.1.2.2. Public Cloud
      • 7.1.2.3. Hybrid Cloud
    • 7.1.3. Services

8. Clinical Risk Grouping Solution Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Population health management
    • 8.1.3. Chronic disease management
    • 8.1.4. Clinical decision support
    • 8.1.5. Fraud detection and prevention
    • 8.1.6. Other

9. Clinical Risk Grouping Solution Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & clinics
    • 9.1.3. Ambulatory surgical centers
    • 9.1.4. Long term care centers
    • 9.1.5. Other

10. Clinical Risk Grouping Solution Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Clinical Risk Grouping Solution Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Clinical Risk Grouping Solution Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Clinical Risk Grouping Solution Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Clinical Risk Grouping Solution Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Clinical Risk Grouping Solution Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Clinical Risk Grouping Solution Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 3M Corporation
    • 11.2.2. 4S Dawn Clinical Software
    • 11.2.3. Apixio
    • 11.2.4. Cotiviti Inc.
    • 11.2.5. Evolent
    • 11.2.6. HBI Solutions
    • 11.2.7. Health Catalyst, Inc.
    • 11.2.8. HealthEC LLC
    • 11.2.9. Lightbeam Health Solutions
    • 11.2.10. MedeAnalytics, Inc.
    • 11.2.11. Nuance Communications, Inc.
    • 11.2.12. Optum, Inc.
    • 11.2.13. RELX (LexisNexis Risk Solution)
    • 11.2.14. ZeOmega
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us